Celldex Therapeutics Competitors and Similar CompaniesClear all
Marker Therapeutics's competitors and similar companies include UCB.
 Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 2018 | Founding Date 1928 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Houston, US HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 888% decrease | Employees 9,052 |
Valuation ($) | Valuation ($) 36.5 m | Valuation ($) 34.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Net income | Net income ($12.2m) (FY, 2025) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company